After Hours
$
8.42
Change
-0.44 -4.97%
Volume
Volume 3,020
May 23, 2022, 5:33 p.m.
Quotes are delayed by 20 min
Previous close
$ 8.51
$ 8.86
Change
+0.35 +4.11%
Day low
Day high
$8.35
$8.94

52 week low
52 week high
$7.32
$32.90

Market cap
$500.82M
Average volume
103,354
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-1.74
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on IPSC
-
Century Therapeutics started at overweight with $40 stock price target at J.P. Morgan
- Tomi Kilgore
-
Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares
- Barron's Online
-
Century Therapeutics sets IPO terms; to offer 10.6 mln shares priced at $18 to $20 each
- Ciara Linnane
Other News on IPSC
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Company Corporate Overview Presentation Apr 2022
- Seeking Alpha
-
10-K: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
What's Behind Bristol Myers Squibb's Latest Partnership?
- Motley Fool
-
PYR, SPRB and BBIO among mid-day movers
- Seeking Alpha
-
Six companies added to Nasdaq Biotech index
- Seeking Alpha
-
Meet members of the 2021 IPO class: oncology-focused biotechs
- Seeking Alpha
-
Century Therapeutics added to Russell 2000 Index
- Seeking Alpha
-
SYRS, BGRY and OPAD among mid-day movers
- Seeking Alpha
-
Century Therapeutics EPS misses by $1.53
- Seeking Alpha
-
- Seeking Alpha
- Loading more headlines...
Press Releases on IPSC
-
Century Therapeutics to Present at Upcoming Investor Conferences
- GlobeNewswire
-
Century Therapeutics to Present at the ASGCT 25th Annual Meeting
- GlobeNewswire
-
Century Therapeutics Added to the NASDAQ Biotechnology Index
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com